Background: Precise regulation of neural precursor cell (NPC) proliferation and differentiation is essential to ensure proper brain development and function. The HCFC1 gene encodes a transcriptional co-factor that regulates cell proliferation, and previous studies suggest that HCFC1 regulates NPC function. However, the molecular mechanism underlying these cellular deficits has not been completely characterized. Methods: Here we created a zebrafish harboring mutations in the hcfc1a gene (the hcfc1a co60/+ allele), one ortholog of HCFC1 and utilized immunohistochemistry and RNA-sequencing technology to understand the function of hcfc1a during neural development. Results: The hcfc1a co60/+ allele results in an increased number of NPCs, neurons, and radial glial cells.
These deficits are associated with the abnormal expression of asxl1 , a polycomb transcription factor, which we identified as a downstream effector of hcfc1a using high throughput RNA sequencing technology. Inhibition of asxl1 activity and/or expression in larvae harboring the hcfc1a co60/+ allele completely restored the number of NPCs to normal levels. Conclusion: Collectively, our data demonstrate a novel pathway in which hcfc1a regulates NPCs and neurogenesis.
Background
Neural precursor cells (NPCs) give rise to the differentiated cells of the central nervous system and defects in the number produced, their proliferation, and/or survival can result in a variety of neural developmental disorders. These disorders include intellectual disability (1), cognitive dysfunction (2), behavioral impairment (3), microcephaly (4), epilepsy (5) , autism spectrum disorders (6) , and cortical malformations (7) . Previous studies have demonstrated a complex network of transcription factors that are responsible for modulating NPC function including SOX2 (8) , SOX1 (9) , NESTIN (10) , and PAX transcription factors (11) . Recent evidence suggests that the HCFC1 gene, which encodes a transcriptional cofactor, is essential for stem cell proliferation and metabolism (12, 13) in a variety of different tissue types, including neural precursors (14) (15) (16) (17) . These data strongly suggest that HCFC1 is part of a more global transcriptional program modulating NPC proliferation and differentiation.
HCFC1 regulates a diverse array of target genes and has been shown to bind to the promoters of more than 5000 unique downstream target genes (18) . Consequently, the molecular mechanisms by which HCFC1 regulates NPC proliferation and differentiation are complex. Mutations in HCFC1 cause methylmalonic acidemia and homocysteinemia, cblX type (cblX) (309541). cblX is an X-linked recessive disorder characterized by defects in cobalamin (vitamin B12) metabolism, nervous system development, neurological impairment, intractable epilepsy, and failure to thrive (19) . Functional analysis of cblX syndrome has provided a platform whereby the function HCFC1 in discrete organs and tissues can be elucidated. For example, in vitro analysis has demonstrated that HCFC1 regulates metabolism indirectly by regulating the expression of the MMACHC gene (12, 14, 15, 19) . These data are further supported by in vivo analysis using transient knockdown in the developing zebrafish (16, 20) . Additional mouse models exist and have demonstrated a function for HCFC1 in diverse cell populations (21, 22) , including a subset of NPCs (17) . However, although it is clear that HCFC1 is essential for NPC function (17) , previous studies have not yet determined a mechanistic basis for the cellular phenotypes observed. Thus, additional studies examining the function of HCFC1 in NPCs are warranted.
We have created a zebrafish harboring a mutation in the hcfc1a gene (hcfc1a co60/+ allele) using CRISPR/Cas9. Zebrafish have two orthologs of HCFC1 and in previous studies, we demonstrated that hcfc1b is important for NPC function (16) . The two zebrafish paralogs have been shown to have divergent functions, as the knockdown of hcfc1b causes facial dysmorphia, but knockdown of hcfc1a does not (20) . Therefore, we asked whether germline mutations in the hcfc1a gene cause defects in neural development. Our results demonstrate that the hcfc1a co60/+ allele results in increased numbers of proliferating NPCs (Sox2+) and hypomotility. Subsequent RNA sequencing on whole brain homogenates obtained from the hcfc1a co60/+ allele identified increased expression of asxl1, which encodes a transcription factor known to modulate the cell cycle (23, 24) . Furthermore, inhibition of asxl1 expression in larvae carrying the hcfc1a co60/+ allele restored the number of NPCs to normal levels. Collectively, our study demonstrates a molecular mechanism by which hcfc1a regulates NPC proliferation and brain development.
Methods

Experimental Model and Subject Details
The experimental model used in this study is the zebrafish, Danio rerio. The hcfc1a co60/+ allele was produced using CRISPR/Cas9 methodology as described (25) . Briefly, a guide RNA (GGTTCATACCAGCCGTTCGT) was designed using publicly available software (ZiFit) (26) . Oligonucleotides from the forward and reverse strand were annealed and ligated into the DR274 vector as described (27) . Guide template DNA was synthesized using PCR amplification with primers (DR274 FWD: TTTGAGACGGGCGACAGAT and DR274 Rev: TTCTGCTATGGAGGTCAGGT) and RNA was synthesized using the MEGAscript T7 in vitro transcription kit. Cas9 was synthesized using the T7 mMessage machine after linearization with PmeI (New England Biolabs) of the Cas9 vector (pMLM3613). A solution (0.2M KCl with phenol red indicator) containing a final concentration of 500ng Cas9 and 70 ng of guide RNA was injected at a volume of 2nL into the single celled embryo and the embryos were grown to adulthood. The hcfc1a co60/+ allele was generated from a single founder (F 0 ), which was outcrossed with 3 independent wildtype (AB) fish to generate 3 families of F1 carriers. Each family consisted of approximately 20 total fish with equal numbers of males and females. To generate subsequent generations, we outcrossed a minimum of 3 F1 individuals with wildtype (Tupfel Long Fin) to obtain a minimum of 3 families of F2 carriers. We subsequently outcrossed F2 carriers (minimum of 3) with wildtype (AB) fish to produce an F3 generation of approximately 3 total families with equal numbers of males and females. Sanger sequencing confirmed mutation and experiments were initiated in the F3 generation.
The Tg(hsp701:HCFC1) was created using Gateway cloning technology. Briefly, the p5e-hsp701, pME-HCFC1 (created from pcDNA6.1 reported in (20) ), p3E-polyA, and the pDestTol2PA were recombined via LR recombination. The resultant vector was co-injected with transposase mRNA synthesized from the pCS2FA vector as previously described (28) .
The experiments described herein were performed in the F2 generation, which was produced from a single founder (F 0 ). The positive F 0 carrier was outcrossed with wildtype (AB) to produce 2 families of F1 individuals and a minimum of 3 carriers of the F1 generation were outcrossed to produce 3 families of F2 carriers that were utilized for the experiments described.
For all experiments, embryos (prior to sexual dimorphism) were obtained by crossing AB wildtype, Tupfel Long Fin wildtype, Tg(hsp701:HCFC1), or hcfc1a co60/+ . Experiments were performed at developmental stages only (0-5DPF). All embryos were maintained in embryo medium at 28 • C.
Genotyping
Genotyping of the hcfc1a co60/+ allele was performed by lysing excised larval tissue or fin clips (adults) in lysis buffer (10mM Tris pH 8.2, 10mM EDTA, 200mM NaCl, 0.5% SDS, and 200ug/ml proteinase K) for 3 hours at 55 • C. DNA was isolated according to standard phenol chloroform : ethanol precipitation procedures. Primers pairs were developed that specifically bind to and amplify the mutated allele and did not amplify the wildtype allele.
The fragment of interest was amplified by standard PCR at an annealing temperature of EdU was detected using the EdU Click-It technology (Fisher) according to manufacturer protocol.
Cell Quantification
For cell quantification, sections were first divided into forebrain, midbrain, and hindbrain regions using two zebrafish brain atlases 1) Atlas of Zebrafish Development (29) and 2) Atlas of Early Zebrafish Brain Development (30). To specify brain regions, major hallmark sub-divisions of each brain section were separated based on age of larvae and the published sections and demarcations present in (30). For example, sections of the developing brain are organized by letters: A-F indicate forebrain sections, G-L are midbrain, and M-R are hindbrain according to the zebrafish brain atlas. After standardization of the brain region by atlas, cells from each section (12-20uM) were counted using the ImageJ cell counter. The ImageJ cell counter allows for the manual counting of cells by marking each cell with a colored square and adds the tallied cell to the quantification sheet. The cell counter allows for the tally of 4 independent groups separately with a different color square. Cells were easily visible across all replicates.
Only biological replicates with high tissue integrity were quantified. For comparison of representative images, equivalent sections are shown to ensure that minor changes in tissue geometry do not affect the overall conclusion. These sections are standardized from the zebrafish brain atlas. For bar graphs, the average number of cells across each brain region were utilized for quantification using approximately, 10-20 equivalent sections/brain region/fish were quantified. The number of animals per group is described in each figure legend. To determine the relative increase/decrease in total cell number, the number of total cells/section was divided by the average number of cells present in wildtype siblings for each brain region analyzed and multiplied by 100. All statistical analysis was performed using total numbers of cells/section/brain region. All immunohistochemistry was validated with quantitative real time PCR (QPCR) of each gene analyzed.
QPCR and in situ hybridization
Whole mount in situ hybridization (ISH) was performed as described by Thisse and Thisse (31) . Briefly, embryos were harvested and dechorionated at the indicated time point and fixed in 4% paraformaldehyde (PFA) (Electron Microscopy Sciences) for 1 hour at room temperature (RT). Embryos were permeabilized with proteinase K (10ug/ml) for the time indicated by Thisse and Thisse (32) . Permeabilized embryos were prehybridized in hybridization buffer (HB) (50% deionized formamide (Fisher), 5X SSC (Fisher), 0.1% Tween 20 (Fisher), 50mg ml -1 heparin (Sigma, St. Louis), 500mg ml -1 of RNase-free tRNA (Sigma), 1M citric acid (Fisher) (460ml for 50ml of HB)) for 2-4 hours and then incubated overnight in fresh HB with probe (50-100ng) at 70°C. Samples were washed, blocked in 2% sheep serum, and incubated with anti-DIG Fab fragments (1:10,000) (Sigma) overnight at 4°C.
Samples were developed with BM purple AP substrate (Sigma) and images were collected with a Zeiss Discovery Stereo Microscope fitted with Zen Software. The asxl1 cDNA probe sequence was amplified using the following primers: FWD: CATCAACACACGGACCTTTG and REV: CAGTGAGTGGGGTGGAAGTT, purified using a DNA purification kit (Fisher), then ligated into the pGEM-T easy vector using the pGEM T-easy Plasmid Ligation Kit (Promega). For RNA sequencing analysis, total RNA was isolated from brain homogenates (N=12/group from 3 biological replicates), analyzed for RNA integrity, and sequenced at
The University of Texas El Paso Border Biomedical Research Center Genomics Core Facility. RNA sequencing was performed in biological triplicate. RNA integrity was assessed with a TapeStation 2200 and the library was prepared with a TruSeq stranded mRNA library preparation kit. Sequencing was performed on a NextSeq500 (Illumina) using a high output kit V2 (150 cycles). For analysis, the sequences were quality trimmed using Trimmomatic (33) and aligned to the Danio rerio genome (build GRCz11) obtained from Ensembl v95 using Tophat2 (34) . Cufflinks (35) was used to determine the differential expression patterns between mutant and wildtype samples.
Tg(hsp701:HCFC1) analysis and rescue experiments.
F2 carriers of the Tg(hsp701:HCFC1) were incrossed and grown at 28 • for 24 hours and then split into two groups, non-heat shock and heat shock. Heat shock was performed for 30 minutes at 38 • and then allowed to acclimate at room temperature for 20 minutes.
Heat shock was initiated at 24 hours post fertilization (HPF) and performed every 8 hours until 5 days post fertilization (DPF). For LY294002 (Selleck Chemicals) rescue, the drug was dissolved in 100% Dimethyl-Sulfoxide (DMSO) (Fisher) and embryos were treated at 24 HPF with a 12uM concentration for a period of 24 hours. Media was removed and embryos were dechorionated and fixed for immunohistochemistry.
For morpholino rescue, 2 nL of a 0.1 mM solution of asxl1 targeting translation inhibiting morpholinos (GTTTGTCCTTCATTTCCTCAGTGTT) or random control morpholinos (Gene-Tools) were injected into offspring of the hcfc1a co60/+ allele. Injected embryos were fixed at 2 DPF and simultaneously stained for the number of Sox2+ and/or EdU+ positive cells. Cells were counted as described above.
Larval Behavioral Assay
Embryos were obtained from an outcross of the hcfc1a co60/+ allele and raised to 5 DPF.
Behavioral quantification was performed using the Zebrabox (ViewPoint Behavior Technology). Larvae were individually tracked for swim speed and total distance swam in a 96 well plate. The behavioral protocol was a total of 15 minutes divided into 5 minute intervals of dark/light/dark conditions. All larvae were acclimated to the dish and housing conditions for 1 hour prior to analysis. Settings for the program include a threshold of 16 and integration period of 300 seconds. Data was measured as total distance traveled (mm) and total swim speed (mm/sec) (Swim Speed= {Total distance traveled in large and small movements) (Smldist+Lardist)}/{Total duration spent by the animal in small and large movements (smldur+lardur)}. Statistical significance was determined according to a Ttest. All experiments were performed in biological triplicate.
Quantification and Statistical Analysis
For all assays, statistical significance was calculated using a Student's T-test to compare the means of two groups. All assays were performed in biological duplicate and triplicate and all QPCR was performed in technical triplicate. For each assay, the total number of animals (N) is indicated in the figure legend. Number of animals was determined based on power analysis conducted from preliminary studies. For all graphs, statistical significance between groups and the P-value is demonstrated in the figure legends. For cell quantification, the number of Sox2+ or EdU+ cells were counted per section and normalized according to the Methods Section above. All sections were sub-divided based on landmarks in the Atlas of Early Zebrafish Brain Development, 2 nd Edition and then separated into specific brain regions (forebrain, midbrain, and hindbrain). All graphs represent error bars as standard error of the mean (SEM).
Results
Production of the hcfc1a co60/+ allele.
Previous studies suggest that HCFC1 regulates NPC function in vitro and in mouse models (14) (15) (16) (17) . HCFC1 is highly conserved across species (19) and zebrafish have been used in previous reports as a model system to understand the mechanisms by which mutations in HCFC1 cause disease (16, 20) . Therefore, we developed a zebrafish harboring a germline mutation in the hcfc1a gene using CRISPR/Cas9 technology. We developed a specific guide RNA (sgRNA) that targets exon 4 of the hcfc1a gene ( Figure 1A ). The sgRNA was injected at the single cell stage and resulted in the net insertion of 13 nucleotides ( Figure   1A ). The introduction of these nucleotides is predicted to introduce a premature stop codon and encode a peptide of 94 amino acids in length (Supplemental Figure 1 ). Full length Hcfc1a is 1778 amino acids in length. Genotyping of the hcfc1a co60/+ allele was developed according to the Materials and methods section, using a reverse primers unique to the mutant allele in the amplification strategy ( Figure 1A ). Positive amplification was indicative of positive carriers ( Figure 1B) , as the primers did not bind to or amplify the wildtype allele. Initial crosses between heterozygous carriers of the hcfc1a co60/+ failed to generate homozygous progeny and did not obey Mendelian inheritance patterns. These results indicate that Hcfc1a is required for early development, which is consistent with previously published studies (21, 22) , however the mechanism for embryonic lethality of the homozygous allele was not explored further here. However, since knockdown of hcfc1a
is not homozygous lethal (20) , we surmised that heterozygous carriers of the hcfc1a co60/+ allele would have defects in overall hcfc1a expression and potential defects in brain development. Therefore, we measured the expression of hcfc1a in carriers of the hcfc1a co60/+ allele and their wildtype siblings using QPCR. We designed primers to detect hcfc1a expression downstream of Exon 4 that span exons 15 and 17 so as to ensure that such primers were capable of detecting changes in total mRNA expression and not deficiencies in Exon 4 only. As shown in Figure 1C , at 2 DPF carriers of the hcfc1a co60/+ allele had a 50% decrease in total hcfc1a mRNA (P<0.05).
Hcfc1a regulates NPC number in vivo.
Several studies suggest that mutation or disruption of Hcfc1 (mouse) mRNA disrupts NPC function. Moreover, we have previously published that hcfc1a is expressed in the developing brain across the forebrain, midbrain, and hindbrain (20) . Therefore, we asked whether the decrease in hcfc1a mRNA expression in carriers of the hcfc1a co60/+ resulted in abnormal NPC development in vivo. To test this, we first measured the expression of sox2 and pax6 using QPCR at 5 DPF. We used sox2 and pax6 as a readouts for NPCs because they are co-localized and established markers of NPCs in the field (36) (37) (38) . At 5 DPF, the expression of both sox2 and pax6 were up-regulated in hcfc1a co60/+ larvae relative to their wildtype siblings (Figure 2A ). We next compared the total number of Sox2+ cells in 5 DPF. Increased NPCs were not observed until 2 DPF ( Figure 2C ) and were sustained until 5 DPF ( Figure 2D ). hcfc1a co60/+ larvae had increased numbers of NPCs in the forebrain, midbrain, and hindbrain regions, with NPCs highly enriched in the ventricular region of the developing brain ( Figure 2E -H and E'-F', arrowheads indicate cells). There was approximately 25-30% more Sox2 + cells per brain region based upon our quantification ( Figure 2) .
The hcfc1a co60/+ allele disrupts cell proliferation.
Based upon previously published data (17) , we hypothesized that the excess NPCs produced undergo cell death. To measure cell death, we performed immunohistochemistry with anti-active caspase 3 antibodies and anti-Sox2 antibodies. As shown in Figure 3A and 3A', we detected approximately 1-2 Caspase+ Sox2+ cells in sibling controls, however larvae harboring the hcfc1a co60/+ allele had on average approximately 5 co-localized cells per/section. As we detected very few total caspase+ NPCs, we next quantified the total number of NPCs in each group to determine the total number of NPCs surviving. As shown in Figure 3B Figure 3E ). We observed an increase in the number of EdU positive cells in the forebrain, although the increase in the forebrain was not significant across multiple biological replicates (P=0.06). Collectively, these data suggest the hcfc1a co60/+ allele results in an increase in NPC proliferation, whereby a sub-population of these NPCs undergo cell death, while the majority of those NPCs produced, survive.
The hcfc1a co60/+ allele is associated with abnormal expression of pro-neural and pro-glial genes.
The hcfc1a co60/+ allele is associated with increased proliferation and an increased number of NPCs. Importantly, the majority of these cells did not undergo cell death and therefore, we asked if the expression of genes associated with differentiation was abnormal. We 
Overexpression of HCFC1 reduces the number of NPCs and decreases neural and glial gene expression.
Our data demonstrates that haploinsufficiency of hcfc1a disrupts NPC function. Previous studies have shown that over-expression of Hcfc1 (mouse) in vitro has the opposite effect (15) . We tested this possibility by creating a transgenic zebrafish expressing human HCFC1 under the control of the heat shock promoter for the hsp701 gene. The efficacy of the hsp701 promoter in zebrafish has been widely established in previous studies (28, (39) (40) (41) (42) (43) . We activated expression of HCFC1 by performing a heat shock as described in the methods section for a period of 5 days. We first measured the mRNA expression of sox2, elavl3 (HuC/D), gfap, and olig2 by QPCR. Activation by heat shock of the Tg(hsp701:HCFC1) allele resulted in decreased expression of all markers analyzed ( Figure  5A ; P<0.05). We next analyzed the number of Sox2+ cells in the presence and absence of heat shock. Activation of the Tg(hsp701:HCFC1) was associated with a decreased number of NPCs across the forebrain (P=4.88568E-05), midbrain (P=0.004359), and hindbrain (P=0.0776) ( Figure 5B , 5C-C').
Asxl1 is overexpressed in animals with the hcfc1a co60/+ allele.
HCFC1 is known to regulate metabolism and craniofacial development via the modulation of MMACHC expression (14, 19, 20) . Therefore, we hypothesized the neural phenotypes associated with mutations in hcfc1a were the direct consequence of defects in mmachc expression. We measured the expression of mmachc in hcfc1a mutants and their wildtype siblings in whole brain homogenates. As shown in Figure 6A , QPCR analysis demonstrated that mmachc expression was unchanged by the hcfc1a co60/+ allele. Based upon these data, we hypothesized that mutation of hcfc1a does not regulate brain development by modulating mmachc expression. To better understand the mechanisms downstream of hcfc1a, we performed RNA-sequencing at 2 DPF using whole brain homogenates from wildtype and hcfc1a co60/+ larvae (Table 1) . Using literature analysis, we identified the asxl1 gene as one a possible downstream effector of Hcfc1a in the developing brain. asxl1 encodes a transcriptional regulator that is essential for proper cell proliferation and whose deletion causes cellular senescence (24, 44) . More importantly, mutations in ASXL1 have been associated with Boring Opitz Syndrome (605039), which has been characterized by profound intellectual disability (45) . According to in situ hybridization, asxl1 expression was restricted to the developing zebrafish brain ( Figure 6B&B' ) and QPCR analysis of brain homogenates validated a 14-fold increase of asxl1 expression at 2 DPF in hcfc1a co60/+ larvae relative to wildtype siblings ( Figure 6C ).
Inhibition of asxl1 restores the NPC phenotype in hcfc1a co60/+ larvae.
Deletion of Asxl1 in mouse embryonic fibroblasts (MEFs) causes growth retardation because Asxl1 regulates the cell cycle via AKT-E2F (24) . Based upon these data, we hypothesized that over-expression of asxl1 in hcfc1a co60/+ larvae promotes proliferation of NPCs. To test this hypothesis, we designed a translational blocking morpholino to inhibit asxl1 expression in hcfc1a co60/+ larvae. We determined the concentration for injection empirically and selected the highest concentration that promoted >70% survival of injected embryos. We injected asxl1 morpholinos or random control morpholinos into hcfc1a co60/+ larvae and their wildtype siblings at the single cell stage and we analyzed the number of EdU positive cells at 2 DPF. As shown in Figure 6D , the injection of random control morpholinos into hcfc1a mutants and their wildtype siblings had no detrimental effects and recapitulated the NPC phenotype previously observed (i.e. increased NPCs, Figure 2 ). However, the injection of asxl1 morpholinos completely restored the number of NPCs to wildtype levels in all brain regions ( Figure 6D , red bars).
Morpholinos can display off-target effects (46) and therefore we sought an alternative route of asxl1 inhibition in hcfc1a co60/+ larvae. Youn and colleagues have demonstrated that ASXL1 (mouse) promotes cell proliferation by binding to AKT kinase and promoting AKT phosphorylation (24) ( Figure 7A ). However, this function can be inhibited by decreasing the activity of PI3K/AKT. Therefore, we treated hcfc1a co60/+ larvae and their wildtype siblings with LY294002, as described in (24) . hcfc1a co60/+ embryos were treated at 24HPF with 12uM LY294002 or vehicle control (DMSO). Vehicle treatment of wildtype and hcfc1a co60/+ larvae recapitulated the NPC phenotype present in hcfc1a co60/+ larvae ( Figure 7B-B'',7C-C'', and 7D-D'') , which was consistent across all brain regions as both the number of Sox2+ cells ( Figure 7E ) and the number of EdU+ cells ( Figure 7F ) were increased in hcfc1a co60/+ larvae. In contrast, treatment with LY294002 reduced the number of cycling cells (EdU+) and the number of NPCs (Sox2+) in hcfc1a co60/+ larvae, consistent with our hypothesis (Figure 7E&F , red bars). To complement these data, we next performed mRNA expression analysis of sox2, asxl1, and cyclin E (ccne1) in treated and untreated hcfc1a co60/+ larvae at 5 DPF. As shown in Figure 7G , treatment with LY294002 resulted in decreased expression of sox2 and asxl1, which was correlated with decreased cyclin E expression (P<0.05).
Defects in neural development are associated with larval hypomotility.
The functional consequences of the defects in brain development in the hcfc1a co60/+ allele are not completely understood. However, mutation of HCFC1 in patients with cblX syndrome is associated with movement disorders (19) . Therefore, we performed larval behavioral assays to determine if the defects in brain development present in larvae with the hcfc1a co60/+ allele were associated with abnormal swim patterns. To test this, we monitored swim behavior of 5 DPF larvae using Zebrabox technology. Upon light stimulus carriers of the hcfc1a co60/+ allele exhibited reduced overall distance swam, but overall speed was not affected ( Figure 8A&B ). These behavioral deficits are consistent with a hypomotility phenotype (47) . Importantly, hcfc1a co60/+ responded normally to dark-light-dark transitions ( Figure 8C) as has been previously demonstrated (48) .
Discussion
Here we demonstrate that the hcfc1a co60/+ allele results in an increase in the number of NPCs during early brain development. This increase in NPC number is a direct consequence of over proliferation of NPCs. Mutations in HCFC1 cause cblX syndrome, a multiple congenital anomaly syndrome, associated with cobalamin deficiencies and significant neurological deficits, among other phenotypes (15, 19) . HCFC1 encodes for a transcriptional co-activator that regulates genes important for metabolism and proliferation (12) . It is suggested that HCFC1 binds to and regulates the expression of >5000 different genes (18) , with various different interacting partners including THAP11 (13) and ZNF143 (49), where mutation of either can cause a cblX like disorder (16, 50) .
Previous reports suggest that HCFC1 regulates NPC function (14) (15) (16) (17) . In vitro, decreased Hcfc1 (mouse) expression increases the number of NPCs and reduces the expression of markers associated with differentiation (14) . These data are consistent with the known function of Hcfc1 in cell proliferation (51) (52) (53) . Mutation of Hcfc1 (mouse) is embryonically lethal (21) and consequently, the in vivo function of HCFC1 has been difficult to characterize. Our results are consistent with this observation as we did not detect homozygous mutant larvae. We sequenced larvae from an incross of hcfc1a co60/+ larvae at 2, 4, and 8 HPF and even at the earliest time point we detected only heterozygous carriers. We did not explore this mechanism further, however in previous studies the murine Hcfc1 mutant allele was subject to compensatory mechanisms and only the paternally inherited allele was viable (21) . Zebrafish do not have sex chromosomes, but future studies are warranted that characterize the inheritance of the hcfc1a co60/+ allele.
Recently a cell-type specific mutant allele was created in which Hcfc1 (mouse) was deleted from a sub-population of neural precursors (NKX2.1+). This cell type specific deletion of Hcfc1 (mouse) induces cell death and defects in differentiation without affecting proliferation. The discrepancy between these results could be explained by many factors including the propagation of neurospheres in vitro and the inability to decipher how the developing microenvironment affects normal physiology. However, some studies have helped to shed light on the latter explanation because the in vivo knockdown of hcfc1b, one of the zebrafish orthologs of HCFC1, resulted in increased NPC proliferation (16) . Thus, the function of HCFC1 is complex, with several unknown cell-type specific functions that can be affected by the surrounding microenvironment of the developing brain.
Here we developed a zebrafish harboring a germline mutation in the hcfc1a gene. We analyzed the effects of this mutation on NPC function. Consistent with the literature (14-16), our allele resulted in an increase in the number of Sox2+ cells and increased cellular proliferation without significant deficits in cell survival. Increased cell proliferation was observed across different brain regions. Strikingly, the increase in NPCs was not associated with increased apoptosis of NPCs, but instead with increased expression of markers associated with neurons and glia. The effects of this increased expression are yet to be elucidated, however studies that provide information on brain volume and the ratio of gray and white matter in the central nervous system are warranted given that the increases in neurons and glia we observed are unique from the differentiation defects observed in previous studies (14, 17) . However, we suspect the difference in phenotype is associated with the type of mutation introduced, the brain microenvironment, the cell population analyzed, and the region of the brain of interest. For example, Minocha and Herr (17) deleted exons 2 and 3 of Hcfc1 using a Cre-Lox system with a cell type specific promoter. The resulting approach introduces the formation of a truncated protein, whereas, our system results in decreased overall expression ( Figure 1 ) more consistent with previous in vitro assays and haploinsufficiency. However our haploinsufficient allele advances the field because unlike the previous in vitro assays (14, 15) , our allele accounts for the broad expression of Hcfc1 which was recently documented by Minocha and colleagues (17) .
HCFC1 regulates a myriad of downstream target genes (12, 18) and therefore, the mechanisms by which HCFC1 regulates NPC function are not clear. The majority of the literature focuses primarily on the function of HCFC1 at the MMACHC promoter in the human syndrome, cblX. cblX disorder is the result of mutations in the HCFC1 gene and these mutations disrupt protein function causing a decrease the expression of MMACHC and a metabolic disorder (14, 19) . Interestingly, mutations in MMACHC cause cblC disorder, which has many overlapping phenotypes with cblX including neurodevelopmental defects (54) . These data led us to hypothesize that HCFC1 regulates NPC function by modulating MMACHC expression. However, the hcfc1a co60/+ allele did not disrupt mmachc expression, however whether our allele causes other metabolic deficits is not known and was not explored further here. For example, mutation of the human HCFC1 gene has been associated with nonketotic hyperglycinemia (55) . Collectively the data presented here suggests that the hcfc1a co60/+ allele disrupts NPC function by a novel molecular mechanism. In addition, these data suggest some divergent function between hcfc1a and hcfc1b, as the latter has been shown to regulate mmachc expression and craniofacial development (20) .
Our results strongly suggest an mmachc independent mechanism underlying the neural developmental phenotypes associated with the hcfc1a co60/+ allele, but we cannot completely rule out that hcfc1b regulates brain development via mmachc expression or that other factors including cobalamin, homocysteine, or methylmalonic acid function aberrantly as a consequence of mutations in hcfc1a. However, RNA-sequencing of brain homogenates provided us a list of potential downstream candidate effectors of hcfc1a. Of those candidates, the asxl1 gene was afforded high priority because of its known role regulating cellular proliferation (24, 44, 56) and for its documented function in mouse embryonic stem cells and neural differentiation (23) . Interestingly, the hcfc1a co60/+ allele causes a 14-fold induction of asxl1 expression. In mouse embryonic fibroblasts, the deletion of Asxl1 causes cellular senescence. We observed increased cellular proliferation and therefore, postulated that an increased level of Asxl1 protein was promoting NPC proliferation in hcfc1a mutant larvae. Consistent with the known function of asxl1 and our hypothesis, knockdown of asxl1 in hcfc1a mutant larvae restored the defects in cellular proliferation, resulting in normal numbers of Sox2+ cells.
Interestingly, ASXL1 has been shown to regulate cell proliferation in other cell types (56, 57) and this activity has been associated with activation of AKT. Based upon these data, we attempted to restore the phenotypes present in the hcfc1a co60/+ allele by inhibiting ASXL1 activity downstream of PI3K (24) . Consistent with this role, the inhibition of ASXL1 activity using pharmacological inhibition completely restored the NPC deficits present in hcfc1a mutants. Thus, our data suggest a mechanism whereby hcfc1a regulates the expression of Asxl1, and the cell cycle during early brain development. However, whether hcfc1a regulates asxl1 by directly binding to the asxl1 promoter is still not known, but interestingly ASXL1 and HCFC1 interact with one another in myeloid cells to regulate proliferation and differentiation (58) . Thus, these two proteins may regulate the activity of one another at multiple levels.
We observed changes in the expression of various markers of neurons and glia. However, the physiological consequences of these changes are currently not known as a viable mouse model has not been developed. Zebrafish have emerged as a model for neurodevelopmental disorders (59) and behavioral assays for seizure (60) and motor deficits (61) have been described. Therefore, we characterized the locomotion of hcfc1a mutants in response to light stimulus (62) . Our results using Zebrabox technology demonstrated reduced motility as indicated by distance travelled without defects in overall speed. Importantly, the decreased motility with light stimulus was not due to an overall defective response to light, as our analysis demonstrated that carriers of the hcfc1a co60/+ allele responded to light as indicated by the "V" like pattern in dark-lightdark conditions (63) . Decreased distance travelled has been previously defined as hypolocomotion and is associated with motor incoordination (64) . Hypolocomotion has been demonstrated in zebrafish models of ALS (61, 65) and fetal akinesia (66) , two disorders characterized by motor deficits. Interestingly, the hypolocomotion we observed was correlated with increased NPCs and defects in the expression of various markers associated with differentiation. We did not observe short convulsions or whirlpool like behaviors in mutant larvae, which would have been indicative of a seizure phenotype and it is likely that the protocol we used to detect behavior does not stimulate seizure like phenotypes. Future studies that use multiple stimuli, including low dose convulsants will likely shed light on the epileptic phenotypes associated with mutations in hcfc1a.
Conclusions
Our study focuses on the function of hcfc1a, one ortholog of HCFC1, during brain development. Specifically, we focus on the function of hcfc1a in modulating NPC number and proliferation. We demonstrate that HCFC1 is essential for the proliferation of NPCs. Importantly, we connect these cellular deficits to a molecular mechanism whereby hcfc1a indirectly regulates asxl1 to control cellular proliferation. Thus, we propose that our system has the potential to inform about the transcriptional program regulating NPC function. 
Abbreviations
Supplementary Files
This is a list of supplementary files associated with the primary manuscript. Click to download.
Supplemental Figure 1 .docx
